Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
If you're over 50 and haven't saved for retirement, it's not too late. Learn essential steps to secure your financial future.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
NovaBridge Crypto cuts 12% of its workforce to accelerate its AI strategy, signaling a wider shift toward AI-driven e...
Bank of America signals a noticeable pullback in card use across its customers, adding to a growing picture of cautio...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...
SpaceX just won FAA clearance for a new re-entry capsule, a move that could redefine the economics of space data retu...
The 2027 COLA could lift benefits, but rising Medicare costs and hold-harmless rules mean many retirees may see littl...
Micron Technology stunned investors by guiding for a $50 billion fourth-quarter revenue, underscoring data-center dem...
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
Bitcoin has fallen out of step with broad money growth, creating a large gap between its price and M2-derived fair va...
A high-profile return to release strategy reshapes expectations for both moviegoers and investors as the devil wears ...
Bitcoin steadies in the upper $77,000s as markets weigh renewed U.S.-Iran talks. Oil prices and Fed pricing will dete...